nach oben

Erschienen in:

01.06.2019 | Case report

Alemtuzumab

Secondary autoimmune multiple sclerosis reactivation presenting as immune reconstitution inflammatory syndrome-like pattern: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Excerpt

A 29-year-old man experienced a secondary autoimmune multiple sclerosis (MS) reactivation presenting as immune reconstitution inflammatory syndrome(IRIS)-like pattern during treatment with alemtuzumab for relapsing remitting multiple sclerosis (RRMS). …

Mavridis T, et al. Iris-like multiple sclerosis exacerbation following alemtuzumab therapy: Lack of response or secondary autoimmune reaction?. Multiple Sclerosis Journal 25 (Suppl. 1): 67-68 abstr. P108, Apr 2019. Available from: URL: http://doi.org/10.1177/1352458519843084 [abstract] - Greece

Titel: Alemtuzumab
Secondary autoimmune multiple sclerosis reactivation presenting as immune reconstitution inflammatory syndrome-like pattern: case report
Publikationsdatum: 01.06.2019
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2019
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-019-63908-2

Springer Medizin

Alemtuzumab

Secondary autoimmune multiple sclerosis reactivation presenting as immune reconstitution inflammatory syndrome-like pattern: case report

Excerpt

Weitere Artikel der Ausgabe 1/2019

Hydroxycarbamide

Antineoplastics

Cotrimoxazole

Tigecycline

Multiple drugs

Hydroxyzine

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Hydroxycarbamide

Antineoplastics

Cotrimoxazole

Tigecycline

Multiple drugs

Hydroxyzine